Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10-year follow-up

Hepatology

Volumn 29, Issue 6, 1999, Pages 1893-1899

  Strasser, S I ^a   Myerson, D ^a   Spurgeon, C L ^a   Sullivan, K M ^a   Storer, B ^a   Schoch, H G ^a   Kim, S ^a   Flowers, M E D ^a   McDonald, G B ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; LIVER DYSFUNCTION; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032994267     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290609     Document Type: Article

References (54)

1. 1 Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, Reitz BA, et al. The declining risk of post‐transfusion hepatitis C virus infection. N Engl J Med 1992 ; 327: 369–373. MEDLINE
2. 2 Neilson JR, Harrison P, Skidmore SJ, King JA, Collingham KE, Milligan DW. Chronic hepatitis C in long‐term survivors of haematological malignancy treated in a single centre. J Clin Pathol 1996 ; 49: 230–232. MEDLINE
3. 3 Ljungman P, Johansson N, Aschan J, Glaumann H, Lonnqvist B, Ringden O, Sparrelid E, et al. Long‐term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995 ; 86: 1614–1618. MEDLINE
4. 4 Locasciulli A, Bacigalupo A, Van Lint MT, Tagger A, Uderzo C, Portmann B, Shulman HM, et al. Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 1991 ; 52: 315–318. MEDLINE
5. 5 Fujii Y, Kaku K, Tanaka M, Kaneko T, Matumoto N, Shinohara K. Hepatitis C virus and liver disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994 ; 13: 523–526. MEDLINE
6. 6 Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion‐transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996 ; 334: 1685–1690. MEDLINE
7. 7 National Institutes of Health Consensus Development Conference panel statement: Management of hepatitis C. Hepatology 1997 ; 26 (Suppl 1): 2–10.
8. 8 Frickhofen N, Wiesneth M, Jainta C, Hertenstein B, Heymer B, Bianchi L, Dienes HP, et al. Hepatitis C virus infection is a risk factor for liver failure from veno‐occlusive disease after bone marrow transplantation. Blood 1994 ; 83: 1998–2004. MEDLINE
9. 9 Maruta A, Kanamori H, Fukawa H, Harano H, Matsuzaki M, Miyashita H, Fujisawa S, et al. Liver function tests of recipients with hepatitis C virus infection after bone marrow transplantation. Bone Marrow Transplant 1994 ; 13: 417–422. MEDLINE
10. 10 Vento S, Cainelli F, Mirandola F, Cosco L, Di Perri G, Solbiati M, Ferraro T, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996 ; 347: 92–93. MEDLINE
11. 11 Strasser SI, Spurgeon CL, Sullivan KM, McDonald GB. Cirrhosis of the liver in long‐term marrow transplant survivors. Blood 1999 ; 93 (in press).
12. 12 McDonald GB, Hinds MS, Fisher LB, Schoch HG, Wolford JL, Banaji M, Hardin BJ, et al. Venocclusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993 ; 118: 255–267. MEDLINE
13. 13 Sullivan KM, Siadak MF. Stem cell transplantation. In: Johnson FE, Virgo KS, eds. Cancer Patient Follow Up. St. Louis: Mosby. 1997 ; 490–518.
14. 14 Sullivan KM. Graft‐versus‐host disease. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. 2nd ed. Cambridge: Blackwell Scientific. 1999 ; 515–536.
15. 15 McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984 ; 4: 116–122. MEDLINE
16. 16 Shuhart MC, Myerson D, Childs B, Fingeroth JD, Perry JJ, Snyder DS, Spurgeon CL, et al. Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. Blood 1994 ; 84: 3229–3235. MEDLINE
17. 17 Shuhart MC, Myerson D, Spurgeon CL, Bevan CA, Sayers MH, McDonald GB. Hepatitis C virus infection in bone marrow transplant patients after transfusions from anti‐HCV positive donors. Bone Marrow Transplant 1996 ; 17: 601–606. MEDLINE
18. 18 Rozman C, Carreras E, Qian C, Gale RP, Bortin MM, Rowlings PA, Ash RC, et al. Risk factors for hepatic veno‐occlusive disease following HLA‐identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant 1996 ; 17: 75–80. MEDLINE
19. 19 Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB, et al. Veno‐occlusive disease of the liver following bone marrow transplantation. Transplantation 1987 ; 44: 778–783. MEDLINE
20. 20 Ganem G, Saint‐Marc Girardin MF, Kuentz M, Cordonnier C, Morinello G, Tebail C, Braconnier F, et al. Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 1988 ; 14: 879–884. MEDLINE
21. 21 Styler MJ, Crilley P, Biggs J, Moul J, Copelan E, Topolsky D, Avalos B, et al. Hepatic dysfunction following busulfan and cyclophosphamide myeloablation—a retrospective, multicenter analysis. Bone Marrow Transplant 1996 ; 18: 171–176. MEDLINE
22. 22 Ozkaynak MF, Weinberg K, John D, Sender L, Parkman R, Lenarsky C. Hepatic veno‐occlusive disease post‐bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991 ; 7: 467–474. MEDLINE
23. 23 Locasciulli A, 457: Cavalletto D, Pontisso P, Cavalletto L, Scovena E, Uderzo C, Masera G, et al. Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy. Blood 1993 ; 82: 2564–2567. MEDLINE
24. 24 Norol F, Roche B, Saint‐Marc Girardin MF, Kuentz M, Desforges L, Cordonnier C, Duedari N, et al. Hepatitis C virus infection and allogeneic bone marrow transplantation. Transplantation 1994 ; 57: 393–397. MEDLINE
25. 25 Erer B, Angelucci E, Lucarelli G, Giardini C, Baronciani D, Galimberti M, Polchi P, et al. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1994 ; 14: 369–372. MEDLINE
26. 26 Ljungman P, Hagglund H, Lonnqvist B, Sonnerborg A, Ringden O. Hepatitis C virus as a risk factor for the development of veno‐occlusive disease of the liver (letter). Blood 1994 ; 84: 1349–1350. MEDLINE
27. 27 Locasciulli A, Bacigalupo A, Van Lint MT, Cavalletto D, Pontisso P, Testa M, Masera G, et al. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1995 ; 16: 407–411. MEDLINE
28. 28 Iqbal S, Vickers C, Elias E. Drug metabolism in end‐stage liver disease. In vitro activities of some phase I and phase II enzymes. J Hepatol 1990 ; 11: 37–42. MEDLINE
29. 29 George J, Murray M, Byth K, Farrell GC. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995 ; 21: 120–128. MEDLINE
30. 30 Joanne C, Paintaud G, Bresson‐Hadni S, Magnette J, Becker MC, Miguet JP, Bechtel PR. Is debrisoquine hydroxylation modified during acute viral hepatitis? Fund Clin Pharmacol 1994 ; 8: 76–79.
31. 31 Epstein RB, Min KW, Anderson SL, Syzek L. A canine model for hepatic venocclusive disease. Transplantation 1992 ; 54: 12–16. MEDLINE
32. 32 DeLeve LD, Wang XD, Huybrechts MM. Cellular target of cyclophosphamide toxicity in the murine liver‐role of glutathione and site of metabolic activation. Hepatology 1996 ; 24: 830–837. MEDLINE
33. 33 Barbaro G, Di Lorenzo G, Soldini M, Parrotto S, Bellomo G, Belloni G, Grisorio B, et al. Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol 1996 ; 91: 2569–2573. MEDLINE
34. 34 Swietek K, Juszczyk J. Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. J Viral Hepat 1997 ; 4: 139–141. MEDLINE
35. 35 Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti‐HCV positive hepatitis. J Hepatol 1995 ; 22: 449–456. MEDLINE
36. 36 Larrea E, Beloqui O, Munoz‐Navas MA, Civeira MP, Prieto J. Superoxide dismutase in patients with chronic hepatitis C virus infection. Free Radic Biol Med 1998 ; 24: 1235–1241. MEDLINE
37. 37 De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, Van Thiel DH, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996 ; 21: 291–295. MEDLINE
38. 38 Mosnier JF, Scoazec JY, Marcellin P, Degott C, Benhamou JP, Feldmann G. Expression of cytokine‐dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology 1994 ; 107: 1457–1468. MEDLINE
39. 39 Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA‐A, B, C, and intercellular adhesion‐1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995 ; 95: 2067–2075. MEDLINE
40. 40 Garcia‐Monzon C, Sanchez‐Madrid F, Garcia‐Buey L, Garcia‐Arroyo A, Garcia‐Sanchez A, Moreno‐Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 1995 ; 108: 231–241. MEDLINE
41. 41 Shulman HM, Gown AM, Nugent DJ. Hepatic veno‐occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987 ; 127: 549–558. MEDLINE
42. 42 Shirai M, Nagashima K, Iwasaki S, Mori W. A light and scanning electron microscopic study of hepatic veno‐occlusive disease. Acta Pathol Jpn 1987 ; 37: 1961–1971. MEDLINE
43. 43 Vonnahme F‐J. Die Leber des Menschen. Rasterelektronenmikroskopischer atlas. The Human Liver. A scanning electron microscopic atlas. Freiburg: S. Karger 1993.
44. 44 Roulot D, Durand H, Coste T, Rautureau J, Strosberg AD, Benarous R, Marullo S. Quantitative analysis of transforming growth factor beta 1 messenger RNA in the liver of patients with chronic hepatitis C: absence of correlation between high levels and severity of disease. Hepatology 1995 ; 21: 298–304. MEDLINE
45. 45 Watanabe K, Iwaki H, Satoh M, Ikeda T, Ichimiya S, Suzuki N, Kudoh T, et al. Veno‐occlusive disease of the liver following bone marrow transplantation: a clinical‐pathological study of autopsy cases. Artif Organs 1996 ; 20: 1145–1150. MEDLINE
46. 46 Strasser SI, McDonald GB. Hepatobiliary Complications of Hematopoietic Stem Cell Transplantation. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver. 8th ed. Philadelphia: Lipincott‐Raven. 1999 ; 1617–1641.
47. 47 Freni MA, Ajello A, Spadaro A, Fava A, Calapristi I, Marafioti T, Alessi N, et al. Class I HLA antigens hepatic display and beta‐2‐microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon. Hepato‐gastroenterology 1997 ; 44: 1295–1301.
48. 48 Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY. The role of hepatitis C virus‐specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997 ; 158: 1473–1481. MEDLINE
49. 49 Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987 ; 69: 369–380. MEDLINE
50. 50 Strasser SI, McDonald GB. Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management. Blood 1999 ; 93: 1127–1136. MEDLINE
51. 51 Strasser SI, Shulman HM, McDonald GB. Chronic graft‐vs‐host disease of the liver: presentation as an acute hepatitis [Abstract]. Hepatology 1997 ; 26 (Suppl): 605A.
52. 52 Locasciulli A, Testa M, Pontisso P, Bacigalupo A, Ljungman P, Frickhofen N, Alberti A. Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1997 ; 19: 237–240. MEDLINE
53. 53 Locasciulli A, Testa M, Pontisso P, Benvegnu L, Fraschini D, Corbetta A, Noventa F, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997 ; 90: 4628–4633. MEDLINE
54. 54 Cesaro S, Petris MG, Rossetti R, Cusinato R, Pipan C, Guido M, Masiero L, et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 1997 ; 90: 1315–1320. MEDLINE